(Q41111990)

26 September 2017

1 reference

title

Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry (English)

1 reference

26 September 2017

Ballantyne CM

1

1 reference

26 September 2017

Bourge RC

2

1 reference

26 September 2017

Domalik LJ

3

1 reference

26 September 2017

Eisen HJ

4

1 reference

26 September 2017

Fishbein DP

5

1 reference

26 September 2017

Kubo SH

6

1 reference

26 September 2017

Lake KD

7

1 reference

26 September 2017

Radovancevic B

8

1 reference

26 September 2017

Taylor DO

9

1 reference

26 September 2017

Ventura HO

10

1 reference

26 September 2017

Yancy CW Jr

11

1 reference

26 September 2017

Young JB

12

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

American Journal of Cardiology

26 September 2017

published in

1 reference

26 September 2017

volume

78

1 reference

26 September 2017

issue

5

1 reference

26 September 2017

page(s)

532-535

1 reference

Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Effect of pravastatin on outcomes after cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Inhibition of growth factor signaling pathways by lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil +/- lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

Niacin revisited: clinical observations on an important but underutilized drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900358-X

10.1016/S0002-9149(96)00358-X

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference